Hijery ny anatiny

Bêta-thalassémie majeure

Induction pharmacologique de la synthèse d'hémoglobine fœtale

Traitement par l’hydroxyurée (hydroxycarbamide)

Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (manokatra rohy)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Loharanon-kevitra‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Rakitra‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (manokatra rohy)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (manokatra rohy)

Banan M.

Loharanon-kevitra‎: Ann Hematol 2013;92(3):289-99.

Rakitra‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (manokatra rohy)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (manokatra rohy)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Loharanon-kevitra‎: Transfusion 2007;47(10):1830-6.

Rakitra‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (manokatra rohy)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (manokatra rohy)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Loharanon-kevitra‎: Blood 1996;87(3):887-92.

Rakitra‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (manokatra rohy)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (manokatra rohy)

Karimi M, Cohan N, Pishdad P.

Loharanon-kevitra‎: Hematology 2015;20(1):53-7.

Rakitra‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (manokatra rohy)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (manokatra rohy)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Loharanon-kevitra‎: Int J Hematol 2012;95(1):51-6.

Rakitra‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (manokatra rohy)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (manokatra rohy)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Loharanon-kevitra‎: Blood 2013;121(12):2199-212.

Rakitra‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (manokatra rohy)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (manokatra rohy)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Loharanon-kevitra‎: Sci Rep. 2022;12(1):2752.

Rakitra‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (manokatra rohy)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (manokatra rohy)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Loharanon-kevitra‎: Haematologica 2004;89(10):1172-8.

Rakitra‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (manokatra rohy)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (manokatra rohy)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Loharanon-kevitra‎: Arch Iran Med 2009;12(3):295-7.

Rakitra‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (manokatra rohy)

Érythropoïétine recombinante (seule ou associée à d’autres agents)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (manokatra rohy)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Loharanon-kevitra‎: J Matern Fetal Med 1999;8(1):1-7.

Rakitra‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (manokatra rohy)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (manokatra rohy)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Loharanon-kevitra‎: Acta Haematol 2004;111(4):189-95.

Rakitra‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (manokatra rohy)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (manokatra rohy)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Loharanon-kevitra‎: Ann Hematol 2001;80(8):492-5.

Rakitra‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (manokatra rohy)

Fetal globin induction--can it cure beta thalassemia? (manokatra rohy)

Perrine SP.

Loharanon-kevitra‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Rakitra‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (manokatra rohy)